Advertisement
Screener

Bluejay Diagnostics, Inc. (BJDX) Increase (Decrease) in Due from Related Parties

2.8 / 5 stars · 68/120 Roast Me

Bluejay Diagnostics, Inc. Increase (Decrease) in Due from Related Parties

Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Due from Related Parties of $2.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2023-08-14

  • Bluejay Diagnostics, Inc. increase (decrease) in due from related parties for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
  • Bluejay Diagnostics, Inc. increase (decrease) in due from related parties for the quarter ending 2022-09-30 was $0.00.
  • Bluejay Diagnostics, Inc. increase (decrease) in due from related parties for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
  • Bluejay Diagnostics, Inc. increase (decrease) in due from related parties for the quarter ending 2022-03-31 was $2.00K, a 50.00% decline year-over-year.
  • Bluejay Diagnostics, Inc. increase (decrease) in due from related parties for fiscal 2022 was $2.00K, a 98.38% decline from fiscal 2021.
  • Bluejay Diagnostics, Inc. increase (decrease) in due from related parties for fiscal 2021 was $123.10K.
  • Bluejay Diagnostics, Inc. increase (decrease) in due from related parties for fiscal 2020 was -$39.10K.
Period endIncrease (Decrease) in Due from Related Parties 3 monthIncrease (Decrease) in Due from Related Parties 6 monthIncrease (Decrease) in Due from Related Parties 9 monthIncrease (Decrease) in Due from Related Parties 12 month
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20
$0.00
derived: sum of 2 quarters · filed 2023-03-20
$0.00
derived: sum of 3 quarters · filed 2023-08-14
$2.00K
10-K · filed 2023-03-20
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2023-08-14
$2.00K
10-Q · filed 2022-11-09
$115.10K
derived: sum of 4 quarters · filed 2023-08-14
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$2.00K
10-Q · filed 2023-08-14
$115.10K
derived: sum of 3 quarters · filed 2023-08-14
$115.10K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$2.00K
10-Q · filed 2023-05-11
$115.10K
derived: sum of 2 quarters · filed 2023-05-11
$115.10K
derived: sum of 3 quarters · filed 2023-05-11
$121.10K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$113.10K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20
$113.10K
derived: sum of 2 quarters · filed 2023-03-20
$119.10K
derived: sum of 3 quarters · filed 2023-03-20
$123.10K
10-K · filed 2023-03-20
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$6.00K
derived: sum of 2 quarters · filed 2022-11-09
$10.00K
10-Q · filed 2022-11-09
-$2.00K
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$10.00K
10-Q · filed 2022-08-10
-$2.00K
derived: sum of 3 quarters · filed 2022-08-10
2021-03-31$4.00K
10-Q · filed 2022-05-09
-$8.00K
derived: sum of 2 quarters · filed 2022-05-09
2020-12-31-$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$39.10K
10-K · filed 2022-03-10
2020-09-30-$27.10K
10-Q · filed 2021-12-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
AETHLON MEDICAL INC (AEMD)United States$0.005B
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71